Filtros de búsqueda

Lista de obras de

(R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes

scientific article published on 21 September 2018

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models

artículo científico publicado en 2016

A neutral CB1 receptor antagonist reduces weight gain in rat.

artículo científico publicado en 2007

A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity

artículo científico publicado en 2010

An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models

artículo científico publicado en 2015

Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite Growth

artículo científico publicado en 2013

Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.

artículo científico publicado en 2013

C-ring cannabinoid lactones: a novel cannabinergic chemotype

artículo científico publicado en 2014

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters

artículo científico publicado en 2008

Conformationally constrained analogues of 2-arachidonoylglycerol

artículo científico publicado en 2007

Controlled-deactivation cannabinergic ligands

scientific article published on 10 December 2013

Correction to an orally active phenylaminotetralin-chemotype serotonin 5-HT7 and 5-HT1A receptor partial agonist that corrects motor stereotypy in mouse models

artículo científico publicado en 2015

Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress

artículo científico publicado en 2015

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

artículo científico publicado en 2010

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands

artículo científico publicado en 2019

Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk

artículo científico publicado en 2018

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study

artículo científico publicado en 2013

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

artículo científico publicado el 1 de octubre de 2012

Heteroadamantyl cannabinoids

artículo científico publicado en 2010

Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward

artículo científico publicado en 2018

Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase

artículo científico publicado en 2012

Oximes short-acting CB1 receptor agonists

scientific article published on 02 August 2018

Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology

scientific article published on 10 September 2019

Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols

artículo científico publicado en 2014

Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.

artículo científico publicado en 2006

The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat.

artículo científico publicado en 2010

Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist

artículo científico publicado el 28 de junio de 2012